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Abstract Although the transcription factor serum response
factor (SRF) has been suggested to play a role in activity-
dependent gene expression and mediate plasticity-associated
structural changes in the hippocampus, no unequivocal evi-
dence has been provided for its role in brain pathology, such as
epilepsy. A genome-wide program of activity-induced genes
that are regulated by SRF also remains unknown. In the pres-
ent study, we show that the inducible and conditional deletion
of SRF in the adult mouse hippocampus increases the epilep-
tic phenotype in the kainic acid model of epilepsy, reflected by
more severe and frequent seizures. Moreover, we observe a
robust decrease in activity-induced gene transcription in SRF
knockout mice. We characterize the genetic program con-
trolled by SRF in neurons and using functional annotation,
we find that SRF target genes are associated with synaptic
plasticity and epilepsy. Several of these SRF targets function
as regulators of inhibitory or excitatory balance and the struc-
tural plasticity of neurons. Interestingly, mutations in those
SRF targets have found to be associated with such human
neuropsychiatric disorders, as autism and intellectual disabil-
ity. We also identify novel direct SRF targets in hippocampus:
Npas4,Gadd45g, and Zfp36. Altogether, our data indicate that
proteins that are highly upregulated by neuronal stimulation,
identified in the present study as SRF targets, may function as
endogenous protectors against overactivation. Thus, the lack
of these effector proteins in SRF knockout animals may lead
to uncontrolled excitation and eventually epilepsy.
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Introduction
Epilepsy is a chronic neurological disorder that affects approx-
imately 1 % of the human population [1]. The development of
epilepsy (epileptogenesis) involves progressive alterations in
synaptic connections (aberrant plasticity), the molecular
mechanisms of which are still poorly understood. The regula-
tion of gene transcription by neuronal activity is an integral
part of adaptive plasticity [2]. Therefore, the identification of
gene expression programs that result from and control long-
term synaptic changes is crucial for understanding the molec-
ular mechanisms that underlie epilepsy [3].
Serum response factor (SRF) is a MADS-box protein
that binds DNA at the CC(A/T)6GG consensus sequence,
known as a CArG box or serum response element (SRE).
SREs are found in promoters of actin cytoskeleton genes
and immediate-early genes (IEGs; [4–6]). SRF-dependent
transcription is activated by neurotrophins or in response
to calcium influx in neurons [7–11]. The inactivation of
SRF leads to a decrease in the expression of such plasticity-
linked genes as Fos, Arc, and Egr1 and produces a deficiency
in hippocampal synaptic plasticity and learning [12, 13]. The
activity of SRF is also important during the development of
the nervous system [14–16] and the regulation of structural
plasticity [17, 18]. The molecules that are involved in physi-
ological plasticity, such as SRF, may also be engaged in path-
ological or aberrant plasticity processes.
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Although SRF has recently been suggested to play a role in
plasticity and mediate structural changes in the hippocampus,
no solid evidence has been provided for its role in brain pa-
thology. Interestingly, the increased binding of SRF to DNA
and upregulation of SRF protein levels were found in the
hippocampus after pilocarpine-induced status epilepticus,
and SRF accumulation and phosphorylation were observed
after kainic acid-induced status epilepticus [19, 20]. These
findings indicate that the transcriptional activity of SRF is
enhanced during epileptogenesis but provide no explanation
for its precise role in this brain pathology. Furthermore, many
SRF-dependent genes that are important for synaptic plasticity
likely still remain unidentified, and no global analysis of SRF-
dependent gene expression in response to neuronal stimula-
tion in the adult brain has yet been reported.
In the present study, we investigated the role of the SRF-
dependent transcriptional program in epileptogenesis using
brain-specific, inducible SRF gene knockout (KO) in mice.
We found that SRF KO mice exhibited an increase in the
susceptibility to spontaneous seizure development and more
severe seizures. We also identified 378 activity-dependent
SRF target genes, among which we distinguished a group
with functions associated with epilepsy and synaptic plas-
ticity that may be responsible for the observed phenotype.
Furthermore, we identified several novel genes that are




Mice with the conditional deletion of Srf in forebrain neurons
(Srf CaMKCreERT2; mutant mice; KO) were generated by
crossing the Srff/f mutant strain (stock nr: 006658; Jackson’s
Laboratories, USA; [12]), carrying the loxP flanked Srf, with
mice expressing Cre recombinase under the control of
neuron-specific CaMKIIα promoter which is activated only
in excitatory forebrain neurons (strain nr: EM:02125; The
European Mouse Mutant Archive; [21]). To obtain time-
specific control of the genetic process, Cre recombinase
was originally fused with mutated ligand-binding domain
of human estrogen receptor to obtain CreERT2 enzyme
which is translocated to the nucleus and active only in re-
sponse to tamoxifen (TAM) treatment. CreERT2-negative
littermates were used as a control (Srff/f; control mice; CTR).
Adult mice, both genotypes, CTR and KO (2–6 months) were
injected intraperitoneally with 1 mg of TAM twice daily
for 5–10 days (Sigma). Experiments were performed at
least 4 weeks after tamoxifen injections. For the ChIP
experiments adult C57BL/6 mice were used. The animals
were treated in accordance with the ethical standards of
European and Polish regulations. All experimental proce-
dures were approved by the Local Ethics Committee. The
mice were bred in the Animal House of Nencki Institute of
Experimental Biology, Warsaw. Animals were housed in indi-
vidual cages under 12-h light/dark cycle with constant tem-
perature (23–25 °C) and with food and water available ad
libitum.
Immunohistochemistry
Mice were transcardially perfused with 4% paraformaldehyde
in PBS. Brains were further fixed in the same buffer overnight
at 4 °C and cut on vibratome on 40-μm slices. Free floating
brain slices were permeabilized, blocked in normal goat serum
for 1 h at room temperature, washed, and incubated with anti-
SRF antibody (1:500) (H-300; Santa Cruz Biotechnology)
overnight at 4 °C. Next, immunochistochemistry was per-
formed using standard procedure with Avidin/Biotin Complex
(ABC) Kit Vectastain PK-6100 (Vector Labs) and visualized
using SIGMAFAST™ DAB (Sigma). For Nissl staining,
brain sections were air dried on slides. Next, the slides were
stained with 0.1 % cresyl violet solution (containing 3 %
acetic acid) for 5 min, washed, dehydrated, cleared in xylene,
and coverslipped.
Western Blotting
Dentate gyrus of the hippocampus was dissected and homog-
enized in a lysis buffer containing 1 mMMgCl2, 5 mMHEPE
S (pH=7.4), 320 mM sucrose, 1 mM Na2F, and protease in-
hibitor cocktail complete (Roche) using Dounce glass homog-
enizer. Protein concentration was measured using BCA Pro-
tein Assay Kit (Pierce). Fifteen microgram of homogenates
was dissolved on 8 % polyacrylamide gels. Western blot
was performed using a standard procedure using anti-SRF
antibody (1:300) (H-300; Santa Cruz Biotechnology). Blots
were reprobed with an anti-α-tubulin antibody (1:5000)
(Sigma) to ensure equal total protein levels. Chemilumines-
cent detection method was used. For the quantification of
individual bands, the scan of the photographic film was ana-
lyzed by densitometry using GeneTools software (Syngene).
Kainic Acid Treatments
CTR and KO animals were injected with 70 nl of 20 mM
solution of kainic acid (KA, Nanocs) in 0.9 % NaCl or saline
at the left CA1 area of the dorsal hippocampus. For
intrahippocampal injection of kainic acid only males were
used. For intraperitoneal injections mice were habituated to
handling and injected with saline for 3 days before the exper-
iments. Then, CTR and SRF KO were injected intraperitone-
ally with 35–50 mg/kg kainic acid or saline. For the microar-
rays profiling experiments only male mice were used.
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Confirmation of microarray results by qRT-PCR was per-
formed on males and females. Six hours after kainic acid-
induced status epilepticus (SE) or 6 h after saline injection,
mice were sacrificed and brain hemispheres were dissected
and incubated overnight in RNAlater solution in 4 °C
(Ambion). Next, the dentate gyrus of the hippocampus was
dissected and frozen in −80 °C for further RNA isolation. For
ChIP assay only males were used. Animals 2 h after
kainic acid-induced status epilepticus were sacrificed
and the hippocampus dissected and used for chromatin
immunoprecipitation.
Surgery and Video-Electroencephalography (EEG)
Surgical Procedures Animals (adult males) were anesthetized
by inhalation of 1.5–2 % isoflurane (Baxter) in oxygen and
placed in a stereotaxic frame and on a heating pad in order to
maintain a constant body temperature. Mice were injected
with kainic acid (with rapidity of 50 nl/min) or saline (control
animals) aimed at the left CA1 area of the dorsal hippocampus
with following coordinates: AP −1.8 mm, ML +1.7 mm, and
DV −2.3 mm from bregma.
Electrode Preparation, Implantation, Electroencephalogra-
phy, and Video Recordings Cortical electrodes were home-
made: a screw was joined to socket contact by copper wire
and welded (Bilaney Consultants Ltd.). Two electrodes were
placed bilaterally into the scull over the frontal cortex and next
two over the cerebellum (first as reference and second as ground
electrode). Bipolar hippocampal electrode (Bilaney Consultants
Ltd.) was implanted into the injected hippocampus using the
coordinates AP −2.0 mm and ML +1.3 mm with bregma as
reference point and DV −1.7 mm below dura. Electrodes were
placed into pedestal (Bilaney Consultants Ltd.) and securedwith
dental acrylate (Duracryl Plus, Spofa Dental, Czech Republic).
After operation, mice were connected to a digital acquisition
system (TWin Clinical Software for EEG, Grass Technologies)
and EEG activity of freely behaving animals was monitored for
18 days in an isolated room. The unit consisted of six cages.
Analysis of Video-EEG Monitoring The occurrence of spon-
taneous seizures was studied by browsing through EEG re-
cord on a computer screen. All motion artifacts were excluded
from analysis. An encephalographic seizure was specified as a
high-amplitude (more than 2× baseline) discharge lasting
more than 5 s. Several seizure parameters were characterized:
behavioral severity (average score), seizure frequency, and
average seizure duration. Behavioral severity was analyzed
frommatching video-EEG recording. Seizures were estimated
based on modified Racine’s scale [22]: score 1—immobility,
facial clonus; score 2—Bwet-dog^ shakes, head nodding;
score 3—piano pose (bilateral clonus of forepaws); score
4—clonic seizures with falling; and score 5—generalized
tonic-clonic seizures. Seizure frequency was specified as a
total number of detected seizures divided by recording
days, and duration was determined on the basis of EEG
recordings. SE severity was analyzed during first 24 h
after intrahippocampal injection of KA. Spontaneous sei-
zures were defined as seizures appearing as early as 24 h
after KA administration.
Gene Expression Profiling Using Microarrays
Total RNAwas isolated from the dentate gyrus using RNeasy
Mini Kit (Qiagen) as described by the manufacturer. Residual
DNAwas removed by digestion with DNase I (Qiagen). RNA
concentration was calculated from the absorbance at 260 nm.
Purity and integrity of RNA was determined using Agilent
RNA 6000 Nano Chips on the Agilent 2100 Bioanalyzer Sys-
tem (Agilent Technologies). A starting amount of 200-ng
high-quality total RNA was used to generate complementary
DNA (cDNA) and complementary RNA (cRNA) with the
Illumina TotalPrep RNA Amplification Kit (Illumina Inc.,
San Diego, CA, USA). The obtained cDNA served as a tem-
plate for in vitro transcription with T7 RNA polymerase and
biotin UTP to generate multiple copies of biotinylated cRNA.
Each cRNA sample (1.5 μg) was hybridized overnight to
MouseWG-6 BeadChip array (Illumina); subsequently, chips
were washed, dried, and scanned with the BeadArray Reader
(Illumina). A total of 22 microarrays were used (5–6 biologi-
cal replicates per group). Analysis and quality control of mi-
croarrays were performed using BeadArray R package. After
background subtraction, data was normalized using quantile
normalization and then log2-transformed. The obtained signal
was taken as the measure of mRNA abundance derived from
the level of gene expression. Statistical analysis of the micro-
array results was performed using a two-way ANOVA (for the
factors genotype and treatment) followed by the estimation of
FDR (percent FDR; false discovery rate) using the Benjamini
and Hochberg method. Microarray data are available in the
NCBI Gene Expression Omnibus (GEO) under accession
number GEO: GSE60772.
Gene ontology enrichment analysis was performed using
DAVID database. Pathway and global functional analysis was
performed using Ingenuity Pathway Analysis (IPA; Ingenuity®
Systems, Qiagen). Additionally, manual analysis of genes’
functions and their role in neurons was assigned on the basis
of published data (manual search of PubMed).
In Silico Analysis of Putative SRF-Binding Sites
Overrepresentation analysis of transcription factor binding
sites (TFBS) in the group of identified genes was performed
using the cREMaG database with default parameters [23].
Independently, using NGD database [24] we identified
genes with at least two putative SRF-binding sites in the
1480 Mol Neurobiol (2016) 53:1478–1493
conserved noncoding sequences between mouse and human,
identified with programs AVID-VISTA [25, 26] within the
−10 kb/+10 kb from Transcription Start Site. Potential SRF-
binding sites were predicted using all the motifs from the
$SRFF family (Genomatix MatBase v. 8.4). Moreover, for
the selected genes (Table 3) we compared previously identified
potential CArG boxes in the human genome [27] to the mouse
sequences. Among the putative SRF-binding sites identified
using the three above approaches (cREMaG, NGD, CArG),
for further analysis, we chose only the sites conforming exactly
to the consensus sequence motif: CC(A/T)6GG or having a
maximum two base pair mismatch (only one mismatch in the
CC or GG) to the consensus sequence.
RNA Preparation and Quantitative Real-Time PCR
Total RNAwas isolated from the dentate gyrus of the hippo-
campus using RNeasy Mini Kit (Qiagen) as described by the
manufacturer. Residual DNAwas removed by digestion with
DNase I (Qiagen). RNA concentration was calculated from
the absorbance at 260 nm and the purity of RNA was deter-
mined by the 260/280 nm absorbance ratio. RNAwas reverse
transcribed with the SuperScript III Reverse Transcriptase
(Invitrogen) according to the manufacturer’s instructions.
Quantitative real-time PCR reactions were performed using
Fast SYBR Green Master Mix (Applied Biosystems) in the
Applied Biosystems 7900HT Fast Real-Time PCR System
using the following cycling conditions: 50 °C for 2 min,
95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s
and 60 °C for 1 min. Primer sequences are presented in
Table 1. Fold changes in expression were determined using
the ΔΔCT relative quantification method. Values were nor-
malized to the relative amounts of ribosomal protein large
P0 (Arbp) mRNA, which was found to be stable across
different phases of KA-induced epilepsy in mice [28].
Chromatin Immunoprecipitation
C57BL/6 mice were injected with KA (35–50mg/kg), and 2 h
after KA-induced status epilepticus or saline injection, hippo-
campi were dissected, chopped (0.5-mm fragments), and fixed
with 1.5 % formaldehyde for 30 min at room temperature,
then glycine was added and incubated for 10 min to quench
formaldehyde (hippocampi from each mouse were processed
separately). Samples were put on ice, washed with ice-cold
phosphate-buffered saline (PBS) supplemented with protease
inhibitor cocktail (Roche) and 1mMPMSF and briefly homog-
enized with an Eppendorf fitting pestle. Samples were centri-
fuged again, washed with PBS with protease inhibitors, and
centrifuged (1.3 g/5 min/4 °C), and the pellet was resuspended
in 2 ml of lysis buffer (5 mM PIPES, pH 8.0, 85 mM KCl,
0.5 % Nonidet P-40, with protease inhibitors), incubated for
10 min on ice, and disrupted using a glass–glass homogenizer.
Crude nuclear extract was collected by centrifugation at 1.3 g
for 10 min at 4 °C and frozen in −80 °C. Nuclear extracts were
pooled and resuspended (3 hippocampi in 200 μl) in high-salt
lysis buffer with protease inhibitors (1× PBS, 1 % Nonidet
P-40, 0.5 % sodium deoxycholate; 1 % SDS). Samples were
sonicated on ice 14 times at 25 % output for 20 s with 30 s
breaks (on ice) using a Branson Sonifier 250 obtaining an av-
erage of 300–500 bp DNA fragments. Samples were diluted
10× with high-salt lysis buffer without SDS (final concentra-
tion of 0.1 % SDS), centrifuged for 15 min to remove cell
debris, and precleared with sonicated salmon sperm DNA/
protein A agarose (50 % slurry) at 4 °C for 30 min with rota-
tion. The DNA content was measured spectrophotometrically,
and equal amounts of DNA were immunoprecipitated over-
night at 4 °C using 5-μg anti-SRF antibody (H-300, Santa
Cruz) or 5 μg of normal rabbit IgG as negative control. Next
day, salmon sperm DNA protein A-agarose beads (Milipore)
were added for 2 h, then the beads were washed with low-salt
wash buffer (0.1 % SDS, 1 % Triton X-100, 2 mM EDTA,
20 mM Tris–HCl, pH 8.1, 150 mM NaCl), high-salt wash
buffer (0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 20 mM
Tris–HCl, pH 8.1, 500 mM NaCl), LiCl wash buffer (0.25 M
LiCl, 1 % Nonidet P-40, 1 % deoxycholate, 1 mM EDTA,
Table 1 List of primer sequences used for qRT-PCR validation of
selected microarray results
Gene symbol Primers sequences
Arbp F: 5′ AGATTCGGGATATGCTGTTGGC 3′
R: 5′ TCGGGTCCTAGACCAGTGTTC 3′
Fos F: 5′ CCCATCCTTACGGACTCCC 3′
R: 5′ GAGATAGCTGCTCTACTTTGCC 3′
Npas4 F: 5′ GCTATACTCAGAAGGTCCAGAAGGC 3′
R: 5′ TCAGAGAATGAGGGTAGCACAGC 3′
Bdnf F: 5′ CTGTAGTCGCCAAGGTGGAT 3′
R: 5′ AGAAGTTCGGCTTTGCTCAG 3′
Syt4 F: 5′ TGACCCGTACATCAAAATGACAA 3′
R: 5′ GTGGGGATAAGGGATTCCATAGA 3′
Gadd45g F: 5′ GAAAGCACTGCACGAACTTCT 3′
R: 5′ CTTTGGCGGACTCGTAGACG 3′
Acan F: 5′ GTGGAGCCGTGTTTCCAAG 3′
R: 5′ AGATGCTGTTGACTCGAACCT 3′
Lcn2 F: 5′ GGGAAATATGCACAGGTATCCTC 3′
R: 5′ CATGGCGAACTGGTTGTAGTC 3′
Pcdh8 F: 5′ TTCCCCTTGCAGCTATTTAGTCT 3′
R: 5′ GAACGTGCTGTATCGGACTGT 3′
Elmo1 F: 5′ GGAGAAGATCCAGCCAGAAAT 3′
R: 5′ GCGAGCATTGAGTTTCCTAAAG 3′
Magoh F: 5′ ACTTTTACCTGCGTTACTACGTG 3′
R: 5′ GTTGTTGGCGTATCGCAATTT 3′
Zfp36 F: 5′ TCTCTGCCATCTACGAGAGCC 3′
R: 5′ CCAGTCAGGCGAGAGGTGA 3′
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10 mM Tris–HCl, pH 8.1), and twice in TE. Antibody-DNA
complexes were eluted with elution buffer (1 % SDS, 0.1 M
NaHCO3), crosslinking was reversed, and proteins were re-
moved by adding 5 M NaCl and proteinase K and incubation
for 2 h at 42 °C, followed by incubation at 65 °C overnight,
next DNA was purified using QIAquick Gel Extraction Kit
(Qiagen). Immunoprecipitated chromatin was used as a tem-
plate for real-time PCR reactions using Fast SYBRGreenMas-
ter Mix (Applied Biosystems) in the Applied Biosystems
7900HT Fast Real-Time PCR System with specific primers
located near the predicted SRF binding sites (Table 2). Obtain-
ed data was analyzed using the ΔΔCT relative quantification
method and calculated as the percentage of the input.
Statistical Analysis
Data on the graphs are expressed as means±standard errors
of the means (SEM) from at least three independent exper-
iments. The statistical analysis of the data was performed
with GraphPad Prism software (GraphPad Software, Inc.).
For comparison of two groups either unpaired t test or
Mann–Whitney test (nonparametric) was used. For compar-
ison of multiple groups, a two-way analysis of variance
(ANOVA) with post hoc Bonferroni’s multiple comparisons
test was used.
Results
Characterization of Srf f/f;CaMKCreERT2 Mice
To investigate the role of SRF in the development of temporal
lobe epilepsy (TLE), Srf gene KOmice were used. Because of
embryonic lethality in Srf-null mice, we used conditional mu-
tants of Srf that were obtained by crossing mice in which the
Srf gene was flanked by loxP sites (Srff/f) with an
CaMKCreERT2 line to ablate its expression exclusively in
Table 2 List of putative SRF binding sites within the evolutionary
conserved regions between mouse and human (10/+10 kb from
transcription start site [TSS]) that were selected for experimental
validation. Mismatched nucleotides (compared with SRF consensus
motif) are underlined. The primer sequences used in the ChIP assays
and location of amplicons (relative to TSS) are indicated. The results of











Fos −309/−300 CCATATTAGG −391/−260 F: 5′ TCCCCCCCTGCGCTGCACCCTCAGA 3′ Y
R: 5′ CAACAGGGACCGGCCGTGGAAACCT 3′
Npas4 −960/−951 CCTAATATGG −1130/−1033 F: 5′ AAAGGGTCTTGGGTAGGTGC 3′ Y
R: 5′ CCTCCGCACAGCTCTAGAAA 3′
−4109/−4100 CCAAATATGG −4207/−4032 F: 5′ TCAGTTGTGTGTGTGCCTGT 3′ Y
R: 5′ GAGCACCCTTCTCTGGAACC 3′
Gadd45g −31/−22 CTATAAAAGG −177/−86 F: 5′ TTTGAGGCTGTGTCATCCCC 3′ Y
−263/−254 CCTTTTAAGG R: 5′ GCCCGCTTTCTGATGCAAAT 3′
Lcn2 −1674/−1665 CCTTTTAAGG −1728/−1605 F: 5′ GTCTCCCATGTGCTGGATAAA 3′ N
R: 5′ GTGACCTCTCCACCCTTCTA 3′
Syt4 −1502/−1493 CCATATGAAG −1623/−1542 F: 5′ TCAACTCTGGGCAATCGGTC 3′ N
R: 5′ TTTCTCCAAAGCTCAGCCCA 3′
Bdnf +4620/+4629 CCAGAAATGG +4418/+4334 F: 5′ GGGAGGAAGAGAGGGAGAGA 3′ N
R: 5′ GCAAGACCAGGGGCTACAAA 3′
−9372/−9363 CCCATTCTGG/CCATTCTGGG −9319/−9154 F: 5′ ACCCCATCTTTGATTTGCAGC 3′ N
R: 5′ GCCCCAGTTGCCCTACATTT 3′
−9336/−9327 CCTAATTTGC N
Magoh −2982/−2973 CCACATGTGG −3026/−2876 F: 5′ GCTGAAGGAAGTGTGCTCCA 3′ N
−2441/−2432 CTTATTTTGG R: 5′ CCTCCCCACCACCATCAAAT 3′
Zfp36 +3473/+3482 CCATACAAGG +3670/+3867 F: 5′ CCCTCTGTCTCTTAGCCCCT 3′ Y
R: 5′ TCACAAGGGAGGCAGTTTCC 3′
Pcdh8 −1061/−1052 TCTAAATAGG −1151/−1035 F: 5′ CAGGTTTCAACGTCACGCTG 3′ N
−1086/−1077 CCCTATTAGA R: 5′ CTGATGCCTTGTTCCGCCTA 3′
Elmo1 +8069/+8078 CCAATTATGG +7998/+7879 F: 5′ ATGTGGCTTGGGAGGTTGAG 3′ N
R: 5′ GTGGGCAGGAGTCAAGTTGA 3′
Arbp exon – – +1509/+1712 F: 5′ AGATTCGGGATATGCTGTTGGC 3′
R: 5′ TCGGGTCCTAGACCAGTGTTC 3′ –
Y yes (SRF binding observed), N no (no SRF binding in the analyzed promoter region detected)
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excitatory forebrain neurons [12, 21]. Additionally, to enable
the time-specific induction of SRF deletion, adult mice
(≥8 weeks old) were injected with tamoxifen, which stimu-
lates the translocation of recombinant Cre recombinase to the
nucleus. Eight weeks after mutation activation, homozygous
adult Srff/f mice (CTR) and Srf gene KO mice that carried a
single copy of Cre recombinase Srff/f;CaMKCreERT2 (KO) were
used for the experiments.
Immunohistochemical analysis of the brain slices obtained
from KO animals (KO = Srff/f;CaMKCreERT2) and control
littermates (CTR = Srff/f) revealed a specific decrease in
SRF protein levels in the dentate gyrus (DG) and CA1
subfield of the hippocampus (Fig. 1a). Similar results that
showed a large decrease in SRF protein levels in the DG
in KO mice were obtained using Western blot (Fig. 1c).
The remaining SRF staining may have resulted from its
expression in astrocytes [29].
We found no evident neuroanatomical differences between
CTR and KO animals’ brains. Nissl staining of hippocampal
sections did not show any structural defects in KO animals
(Fig. 1b). Similarly, the staining of nerve fibers with a zinc
transporter member 3 (Znt3)-specific antibody revealed no
significant differences in mossy fiber projections in CTR
and KO adult brains (data not shown). Thus, the selective
deletion of SRF in adult forebrain neurons did not cause gen-
eral morphological abnormalities as a consequence of SRF
deletion during the early stages of development [15, 14].
SRF Deficiency Enhances Kainic Acid-Induced
Epileptogenesis
To test whether SRF deficiency in the adult brain is sufficient
to cause spontaneous aberrant neuronal activity, electroen-
cephalograms (EEGs) were recorded from sham-operated,
saline-injected animals (n=6 per group, males). EEG activity
was monitored daily for 18 days, 24 h/day, beginning 7 days
after electrode implementation. EEGs were recorded from
hippocampal and cortical electrodes. Sham-operated CTR
and KO animals did not develop spontaneous seizures under
basal conditions (data not shown). However, in all of the ex-
periments performed in CTR and KOmice, three of 40 female
KOmice developed seizures after i.p. saline injection, and this
phenomenonwas not observed in KOmales and in CTRmice.
To study the phenotype of KO animals in the context of
epileptogenesis, we used the kainic acid model of TLE.
Because SRF KO animals were created on a C57BL/6
genetic background and mice with this genetic background
do not show neurodegeneration upon systematic adminis-
tration of kainic acid (data not shown and [30]), epilepsy
was induced by an intrahippocampal injection of kainic
acid [30]. To detect seizures, animals (n=6 per group)
were monitored by EEG video continuously for 18 days,
24 h/day, starting just after the intrahippocampal kainic
acid administration. During the 18 days of recordings, all
of the CTR and KO mice developed seizures.
During the first 24 h, we did not observe any differences in
latency, number of seizures, seizure frequency, and seizures
score (Supplementary Fig. S1). Also, the latency to the first
spontaneous seizure did not significantly differ between KO
and CTR animals (55.50±12.57 h vs. 49.17±12.95 h;
Student’s t test, p>0.05; Fig. 2c). Importantly, however,
the seizure frequency was higher in KO animals than in CTR
animals (3.13±0.80 seizures/day vs. 0.81±0.19 seizures/day,
respectively; Mann–Whitney test, p<0.05; Fig. 2d). The be-
havioral analysis of spontaneous seizures revealed that KO
animals developed more severe seizures than CTR animals
(Mann–Whitney test, p<0.01; Fig. 2e). However, average
spontaneous seizure duration did not significantly differ be-
tween KO and CTR animals (35.7±2.8 vs. 30.0±2.6 s, respec-
tively; Student’s t test, p>0.05; Fig. 2f). Similar epileptic phe-
notypes were observed for another cohort of animals (n=12
per group) that were monitored by EEG video continuously
for 7 days, 24 h/day, 10 days after kainic acid administration
(data not shown). Altogether, our findings indicate that the
lack of SRF-enhanced epileptogenesis.
Loss of SRF Leads to Specific Deficits in Activity-Induced
Gene Expression
To investigate the molecular mechanisms that underlie the
consequences of SRF deletion, we sought to identify SRF-
dependent activity-induced genes. Global gene expression in-
duced by intraperitoneal injection of kainic acid was analyzed
by microarrays. We did not observe significant differences in
seizures severity and latency to seizures (score 4 or 5) in CTR
vs. KO animals (Supplementary Fig. S2). Six hours after sei-
zure induction (i.e., seizure severity=5, based on a modified
Racine scale) or saline injection, CTR and KO animals were
sacrificed, and the DG was microdissected and used for RNA
isolation. To identify SRF-regulated genes, we used Illumina
MouseWG-6 v. 2.0 Expression BeadChips that include 45,
281 transcripts. We focused our microarray analysis on the
DG because (i) it is not vulnerable to kainic acid-induced
excitotoxicity, (ii) it undergoes aberrant plasticity, and (iii)
DG circuitry controls seizure propagation into the hippocam-
pus [31, 32]. Kainic acid induces recurrent seizures, and the
selected time point (i.e., 6 h) after the induction of status
epilepticus enabled us to observe not only late-response
genes but also early-response genes (see Fig. 3; e.g., Fos,
JunB, FosB, Egr2, Egr4).
The statistical analysis of the microarray results showed no
significantly downregulated transcripts under basal conditions
(i.e., in saline-treated animals) in the DG in SRF KO mice,
with the exception of Srf itself (Tukey’s test, p<0.05; fold
change<0.66). Moreover, two transcripts (Arsi and Sstr1)
were significantly upregulated in KO mice compared with
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CTR mice (Tukey’s test, p<0.05; fold change>1.5). This re-
sult was consistent with our EEG recording data, showing no
difference in neuronal activity in CTR vs. KO animals under
basal conditions (data not shown).
In contrast, comparisons of the gene expression profiles of
the two genotypes (KO and CTR) in response to kainic acid-
induced status epilepticus showed robust differences (Fig. 3a).
Importantly, however, the loss of SRF in adult neurons did not
cause general impairment in activity-dependent gene expres-
sion in the DG. Upon seizure induction, 3241 transcripts were
significantly up- or downregulated in CTR animals (fold
change>1.5 or<0.66; Tukey’s test, p<0.05) (Fig. 3b). Among
this group, only 729 probes were differentially regulated by
KA in KO as compared to CTR (fold change>1.5 or<0.66;
Tukey’s test, p<0.05). The remaining 2512 probes (3241−
729=2512; 77.5 %) did not meet the criteria (fold change
CTR KA vs. KO KA: >1.5 or <0.66 and Tukey’s test,
p<0.05). Thus, SRF deficiency in adult neurons altered only
a subset of genes, suggesting the specificity of the regulation.
To further restrict our analysis and obtain a list of the most
significantly changed transcripts, we performed a two-way



































SRF immunoreactivity Nissl staining
a b
CTR (Srf  ) f/f KO (Srf                  )f/f;CaMKCreER
T2
Fig. 1 Conditional deletion of SRF in the adult hippocampus. a
Immunohistochemical staining of SRF in the hippocampus in control
(CTR; Srff/f) and knockout (KO; Srff/f;CaMKCreERT2) animals. Serum
response factor elimination was observed in the dentate gyrus (DG) and
CA1 subfield of the hippocampus.bNissl staining of hippocampal sections
fromCTR andKOmice. No neuroanatomical differences were observed in
the hippocampus in KO mice. Scale bar=a', b' 200 μm, c'–f' 400 μm. c
Loss of two SRF isoforms (67 and 62 kDa) in protein extracts from
DG in KO mice compared with CTR (Western blot and quantification
of Western blot results), each line represents a single, independent
animals, **p<0.01 (Mann–Whitney test)
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(FDR) correction at the 1 % level. Using this approach,
we identified 431 probes (378 genes) with a significantly
altered expression profile as a result of SRF knockdown
after kainic acid (ANOVA, genotype × treatment interac-
tion, p<0.0005; correction FDR<1 %; multiplicity of
changes in CTR animals after the administration of kainic
acid >1.5 or <0.66, Table S1).
Among those 378 genes, two main groups of genes were
clearly distinguishable: (i) genes upregulated in CTR animals
in response to kainic acid (216 genes) and not changed or
upregulated to a lesser extent in KO animals after kainic acid
and (ii) genes downregulated in response to kainic acid in
CTR animals (162 genes) and not changed or inhibited to a
lesser extent in KO animals after kainic acid. Genes with the
most prominent differences in the expression profile between
the two genotypes after kainic acid are shown in the heatmaps
(Fig. 3a: 62 transcripts upregulated after kainic acid in CTR
animals >2.5, fold change in KO vs. CTR after kainic acid<
0.51; Fig. 3b: 15 transcripts downregulated after kainic acid in
CTR animals <0.4; fold change in KO vs. CTR after kainic
acid >1.96). The probes are ordered by fold induction in CTR
animals after kainic acid-induced status epilepticus. The genes
that were chosen for further analysis (as described in the next
paragraph; i.e., functions associated with the regulation of
neuronal excitability and structural plasticity) are shown in
bold. The values correspond to the indicated fold change (lin-
ear scale). To identify the overrepresentation of transcription
factor binding sites (TFBSs) in the group of identified genes,
we performed an in silico analysis using the cis-regulatory
elements in the mammalian genome (cREMaG) database
[23]. We found a significant overrepresentation of SRF bind-
ing sites in the group of 216 genes that were upregulated after
kainic acid, suggesting the contribution of genes that are di-
rectly regulated by SRF (3.7-fold higher than expected by
chance, p=0.0194). Additionally, a significant overrepresen-
tation of MEF2A, another MADS-box family transcription
factor, was also found (3.7-fold higher than expected by
chance, p=0.0184).
Functional Classification of SRF-Dependent Genes
To functionally classify the identified SRF-dependent tran-
scripts, lists of downregulated and upregulated genes were
analyzed by Gene Ontology (GO, DAVID). In the group
of genes with decreased abundance in KO animals, the
overrepresentation of transcripts that are involved in Behavior
(4.1-fold enrichment, p=3.48E−6; e.g.,Egr1,Egr2,Bdnf,Ntrk2,
Cyr61, Nr4a2, andNr4a3) andMAPK signaling pathway (6.3-
fold enrichment, p=9.71E−11; e.g., Ntrk2, Bdnf, Rps6ka3,
Gadd45g, Map2k3, Mapkapk3, and Map3k5) was observed.
To further extend the functional analysis, Ingenuity Path-
way Analysis (IPA; Ingenuity® Systems, Qiagen) was applied.
The Diseases and Bio-Functions analysis revealed Neurological
a
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Fig. 2 Lack of SRF increases number and duration of spontaneous
seizures in the kainic acid model of TLE. a Schematic representation
of the experimental design. b Representative EEG recordings of a
spontaneous seizure in a CTR mouse and KO mouse, with a
hippocampal (h) electrode and cortical (c) electrode (CTR, 5 days
after intrahippocampal kainic acid injection, 33 s duration, behavioral
severity on Racine scale=3; KO, 6 days after intrahippocampal kainic
acid injection, 36 s duration, behavioral severity on Racine scale=5).
The beginning and end of the seizures are indicated by arrows. c CTR
and KO animals did not differ in the latency to the first spontaneous
seizure. d Knockout animals developed a greater average number of
seizures per day than CTR animals (Mann–Whitney test, p<0.05). e
Knockout animals showed more severe behavioral seizures measured
according to Racine’s scale (Mann–Whitney test, p<0.01). f The mean
duration of spontaneous seizures was not significantly different in the
KO group compared with the CTR group (Student’s t test, p>0.05). All
EEG recordings were conducted in males
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Fig. 3 Microarray analysis shows
that SRF is an important regulator
of gene transcription in response to
kainic acid-induced status
epilepticus. The figure shows the
results of gene expression profiling
performed on RNA isolated from
the dentate gyrus of the
hippocampus in control (CTR) and
Srf conditional knockout (KO)
mice 6 h after kainic acid-induced
status epilepticus (KA;
intraperitoneal injection) or saline
injection (saline). Twenty-two
animals (males) were analyzed
(5/6 animals per each genotype/
treatment combination). a Scatter
plot showing fold change values
for KA responding genes in CTR
and SRF mutants. b Pool of 3241
probes which expression was
significantly changed at least 1.5
fold after KA (fold change>1.5 or
<0.66; Tukey’s test, p<0.05). Red
dots indicate population of genes
(729 probes) differentially
regulated in SRF KO as compared
to CTR (fold change CTR KAvs.
KOKA >1.5 or <0.66 and Tukey’s
test, p<0.05). The red lines indi-
cate microarray probes changed by
kainic acid at least 1.5 fold. c, d In
the heatmaps, each column corre-
sponds to one animal with the in-
dicated genotype/treatment combi-
nation. Rows represent transcripts
as indicated on the right. Colors
indicate normalized expression
values as shown by the scale at the
bottom (log2 change). The results
for the 77 transcripts with the
highest changes after kainic acid-
induced status epilepticus in KO
vs. CTR are shown (fold change in
response to kainic acid >2.5 or
<0.4, genotype × treatment inter-
action, FDR<1 %; fold change in
KO vs. CTR after kainic acid
>1.96 or <0.51). Transcripts are
ordered by fold change in CTR
animals treated with kainic acid vs.
saline. The values correspond to
the indicated fold change (linear
scale). The transcripts that were
chosen for further analysis are
shown in bold. c Selected genes
upregulated in CTR animals in
response to kainate but not
changed or upregulated to a lesser
extent in KO animals after kainic
acid. d Genes downregulated in
response to kainic acid in CTR an-
imals but not changed or inhibited
to a lesser extent in KO animals
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Disease as a top-associated category (68molecules; p=4.55E−25
to 3.58E−04). The results of the analysis showed a significant
correlation with annotations: Epilepsy (35 genes; p=8.51E−19;
Neurological Disease category; e.g., Bdnf, Cacna1h, Fos,
Gadd45g, Zfp36, Cyr61, Egr1, Egr2, and Egr4), Plasticity of
Synapse (9 genes; p=0.000103; nervous system development
and function category; e.g., Bdnf, Ntrk2, Pcdh8, and Vgf), and
Outgrowth of Neurites (21 genes; p=0.0000411; Nervous Sys-
tem Development and Function category; e.g., Npas4, Bdnf,
Ntrk2, andGpr3). In addition to GO and IPA, a manual analysis
of gene function was performed, and their role in neurons was
assigned based on published data (manual search in PubMed).
Several functional groups were found, including (i) transcription
factors and other regulatory proteins (e.g., Fos, Npas4, Fosb,
Junb, Egr1, Egr2, Egr4, Atf3, Sp7, and Cited2) and (ii) genes
with functions associated with the regulation of neuronal excit-
ability and structural plasticity of dendritic spines (e.g., Fos,
Npas4, Bdnf, Syt4, Gadd45g, Acan, Lcn2, Pcdh8, Elmo1,
Magoh, and Zfp36; Table 3).
The functional analysis of the group of SRF targets was
consistent with the reported roles of SRF in the regulation of
neurite outgrowth, synaptic plasticity, and behavior [15, 8, 12,
13, 48]. Thus, the identified SRF targets could explain the
seizure-vulnerable phenotype observed in KO animals.
Identification of SRF Direct Targets
A group of genes with functions associated with the regulation
of neuronal excitability and structural plasticity of spines was
selected for validation. Microarray data were verified using
quantitative real-time polymerase chain reaction (qRT-PCR;
saline: n≥5 for each genotype; kainic acid: n≥7 for each geno-
type) for the selected transcripts. An increase in the expression
level 6 h after kainic acid stimulation (intraperitoneal KA in-
jection) and dependence on the transcription factor SRF was
confirmed for FBJ osteosarcoma oncogene (Fos; p<0.001),
lipocalin 2 (Lcn2, NGAL; p<0.01), neuronal PAS domain pro-
tein 4 (Npas4; p<0.01), brain-derived neurotrophic factor
(Bdnf; p<0.05), aggrecan (Acan; p<0.001), protocadherin 8
(Pcdh8; p<0.05), zinc finger protein 36 (Zfp36; tristetraprolin
[TTP]; p<0.01), mago-nashi homolog, proliferation-associated
(Magoh; p<0.05), synaptotagmin IV (Syt4; p<0.05), engulf-
ment, and cell motility 1 (Elmo1; p<0.001), and growth arrest
and DNA-damage-inducible 45 gamma (Gadd45g; p<0.05)
two-way ANOVA genotype×treatment interaction, Bonferroni
multiple-comparisons test (Fig. 4).
To determinewhich of the selected SRF-dependent genes are
direct targets of SRF, we analyzed putative SRF binding sites
within the evolutionary conserved regions between mouse and
human, using two database tools, namely cREMaG [23] and
NGD [24] (see BMaterials and Methods^ section for details).
Additionally, we searched the human CArGome (according to
the group of Miano; [27]) for potential CArG boxes that are
conserved in mouse. Among the pool of potential SRF-binding
sites identified with the above methods, only the motifs with a
maximum of two mismatches to the CArG box consensus [CC
(A/T)6GG] and with at most one mismatch in CC or GG were
selected for the experimental validation.
To identify direct targets of SRF bound in vivo to the gene
promoters in the hippocampus, we applied a model of kainic
acid-induced status epilepticus. We investigated recruitment of
the endogenous transcription factor SRF to the identified re-
gions of selected genes using chromatin immunoprecipitation.
Chromatin from the hippocampus in C57BL/6 mice that were
treated with kainic acid (intraperitoneal kainic acid injection,
2 h after seizure onset) or naive mice was immunoprecipitated
using an anti-SRF antibody or normal immunoglobulin G
(IgG) to determine the background, followed by qRT-PCR am-
plification with specific primers (for the list of primers and
potential CArG boxes, see Table 2). We observed the in vivo
binding of SRF to the promoter of Fos under basal conditions
(i.e., in naive animals), whereas a significant in vivo enrich-
ment of SRF binding 2 h after seizure induction was observed
forNpas4,Gadd45g, and Zfp36 (Fig. 5). The binding of SRF to
the promoters of those genes indicated direct regulation by
SRF. They also presented a full CArG box consensus (or one
mismatch in the case of Zfp36) in the identified SRE sequences.
In contrast, we did not observe significant enrichment in SRF
occupancy at potential CArG box regions of other analyzed
genes (Lcn2, Syt4, Bdnf, Magoh, and Pcdh8). Altogether, we
identified a group of novel SRF targets in neurons, which could
explain the epilepsy-vulnerable phenotype observed in KO an-
imals (Table 3). We showed that three of those genes (Npas4,
Gadd45g, and Zfp36) are novel direct targets of SRF in the
hippocampus in vivo, whereas the other identified genes are
likely to be indirectly regulated by SRF in neurons.
Discussion
The present study assessed the behavioral and transcriptional
effects of SRF deficiency in neurons in the context of
epileptogenesis. Animals with adult, neuronal deletion of SRF
developed amore severe seizure phenotype comparedwith CTR
animals in a kainic acid model of TLE. Using genome-wide
analysis of activity-induced genes, we identified 378 genes that
are differentially expressed in the hippocampal dentate gyrus of
SRF-deficient mice, including regulators of inhibitory/excitatory
balance and structural plasticity of neurons, together with three
new SRF direct targets (Npas4, Gadd45g, Zfp36).
SRF is an Important Transcription Factor in Epilepsy
Epilepsy is a clinically relevant form of hyperexcitability-
associated brain pathology. Genes that are activated during
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seizures may contribute to epileptogenic processes via network
reorganization that leads to hyperexcitability or via compensa-
tory or protective mechanisms. In the present study, we uncov-
ered SRF as an important transcription factor (TF) that regu-
lates epileptogenesis. The deletion of SRF in the adult hippo-
campus increased the epileptic phenotype, manifested by more
severe and frequent spontaneous seizures (Fig. 2), despite
similar severity of acute seizures (Supplementary Fig. S1).
Activity-induced gene expression in neurons might also be
regulated by the transcription factors CREB and MEF2.
Despite partially overlapping patterns of gene expression,
the inactivation of these TFs leads to divergent consequences.
CREB deficiency decreases neuronal excitability and sup-
presses epileptogenesis [49–51]. MEF2 was shown to de-
crease the number of excitatory synapses and weaken neuro-
nal strength [52, 53]. MEF2A binding sites, along with SREs,
were identified in the present study as TF binding sites that
were overrepresented in the promoters of genes regulated by
SRF, suggesting that SRF andMEF2 can activate similar tran-
scription programs in neurons.
Table 3 SRF-dependent gene candidates that are important for the
regulation of neuronal homeostasis. Summary and functional
categorization of selected genes that represent potential candidates
that may explain the SRF KO mouse phenotype of enhanced
epileptogenesis. All of the genes are located in the deletion/duplication
regions in human patients and are candidates for mental retardation
or neurocognitive disabilities (based on DECIPHER database; http://
decipher.sanger.ac.uk/; accessed July 7, 2014)




Fos IEG, regulator of neuronal excitability; expression induced in response to neuronal
activity (e.g., after seizures); activated in human epileptic neocortex [75]; Fos
KO mice have more severe kainic acid-induced seizures and increased neuronal
excitability [70]
Intellectual disability 290148
Npas4 Transcription factor, IEG, selectively induced by Ca2+ influx; regulates
homeostatic balance between excitation and inhibition in neurons by controlling
the number of γ-aminobutyric acid-releasing synapses on excitatory neurons;
Npas4 KO animals are prone to seizures [58, 59]
Intellectual disability, delayed speech
and language development
265913
Bdnf Pro-plasticity neurotrophin, expression bi-directionally regulated by neuronal ac-
tivity; regulates maturation and function of inhibitory synapses [33] as well as
promotes synaptic transmission and synaptogenesis; activated in human epilep-
tic neocortex [75]; lower serum BDNF levels were found in epileptic patients
who suffer more frequent seizures [34]; in contrast, Bdnf KO mice display
reduced epileptogenesis [35, 36], but conditional KOs do not have severely
altered kindling [37]
Intellectual disability, delayed speech
and language development
251208
Syt4 Upregulated in response to depolarization or seizures [38, 39]; modulates synaptic
function by modulating BDNF release [62]; possible involvement in homeostatic
plasticity; Syt4 KO mice exhibit enhanced epileptiform responses [62]
Delayed speech and language
development
250666
Gadd45g Member of the GADD45 family associated with DNA damage repair and DNA
demethylation; other members of GADD45 family (GADD45a and GADD45b)
are involved in neurite outgrowth and activity-induced DNA demethylation
(e.g., Bdnf and Fgf; [40, 63]); activated in human epileptic neocortex [75]
Autism, intellectual disability 270400
Acan Component of perineuronal nets around parvalbumin interneurons; disruption of
perineuronal nets leads to seizure-like activity in hippocampal cultures [72]; loss
of aggrecan staining is observed after status epilepticus (1–2 weeks; [31])
Intellectual disability 261718
Lcn2 Small, inducible, secreted protein, identified as a protein associated with matrix
metalloproteinase-9 [42]; Lcn2 KO animals show increased spine density and
neuronal excitability in hippocampus and amygdala [64, 74]
Autism, severe intellectual disability 289308
Pcdh8 Upregulated in response to neuronal activity or seizures; required for induction of
long-term potentiation [43]; regulates dendritic spine number [65]; other members
of Pcdhs family (Pcdh10 and Pcdh19) are associated with neuropsychiatric dis-
orders (epilepsy, mental retardation, autism-spectrum disorders; [44, 45]
Intellectual disability 260940
Elmo1 Regulates actin cytoskeleton reorganization; localized to excitatory synapses and is
required for spine formation in hippocampal neurons [66]
Autism, severe intellectual disability 289704
Magoh Core protein of the exon junction complex that regulates metabolism of spliced
mRNA; targets mRNA for nonsense-mediated decay; controls brain size by
regulating neural stem cell division [46]; lack of another exon junction complex
component, eIF4A3, increases synaptic strength and GLUR1 AMPA receptor
abundance at synapses and increases Arc protein levels [47]
Intellectual disability 272313
Zfp36 RNA-binding protein; interacts with AU-rich sequences in the 3′ untranslated
region of targeted mRNAs and promotes their degradation; activated in human
epileptic neocortex [75]
Global developmental delay 277936
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Possible Role of SRF-Dependent Genes in the Development
of Epilepsy
Epilepsy is associated with robust synaptic plasticity that oc-
curs at the cellular level caused by changes in gene expression
[54]. Previous studies on SRF-dependent transcription in neu-
rons focused mainly on basal gene expression or were per-
formed using in vitro models [55, 56]. Although previous
studies investigated the program downstream of SRF (recently
reviewed by [57]), SRF-dependent transcription in neurons
was focused mainly on a basal gene expression or were per-
formed using in vitro models [55, 56]. SRF is one of the major
regulators of plastic changes [12, 13]. This large-scale study of
SRF-controlled transcription programs under in vivo condi-
tions provides more insights into the molecular mechanisms
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Fig. 4 SRF is required for the activation of several plasticity genes in kainic
acid-induced status epilepticus. The results obtained with microarray analy-
sis were verified using qRT-PCR. qRT-PCR amplification of 11 transcripts
from control (CTR) and knockout (KO) DG (saline, n≥5 for each genotype;
kainic acid, n≥7 for each genotype; males and females) revealed an increase
in mRNA levels in CTR animals in response to kainic acid stimulation (6 h
after intraperitoneal injection of KA), which was abolished in KO animals.
*p<0.05, **p<0.01, ***p<0.001 (two-way ANOVA followed by


















































Fig. 5 Endogenous SRF binds to the promoter regions of Fos, Npas4,
Gadd45g, and Zfp36. The recruitment of the endogenous transcription
factor SRF to the identified regions of selected genes was analyzed using
chromatin immunoprecipitation with SRF-specific antibody, followed
by qRT-PCR with primers surrounding predicted SRF-binding sites
(for primer sequences and locations, see Table 2). Data are plotted as
a percentage of input and are the averages of three independent
experiments±SEM. A fragment of Arbp exon was used as a negative
control. The level of background was determined with normal IgG.
Genes with SRF bound to their promoter fragments (Fos, Npas4,
Zfp36, and Gadd45g) are marked with frames (>2-fold increase in
precipitation level compared with Arbp exon and IgG controls).
Kainic acid-induced status epilepticus (KA, intraperitoneal injection)
enhanced the binding of SRF especially to the promoters of the
Npas4, Zfp36, and Gadd45g genes. All ChIP analysis were conducted
in males
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found a large number of SRF-dependent genes associatedwith
synaptic plasticity and epilepsy, the expression of which was
decreased in SRF KO mice after seizures.
Functional annotation revealed that many of the SRF
targets we have identified are known as regulators of
inhibitory/excitatory balance, structural plasticity, and
mRNA translation (see Table 3). Control of inhibitory/
excitatory balance in neurons can be regulated by Npas4,
which is an activity-dependent TF that controls inhibitory
synapse development and a number of γ-aminobutyric ac-
id-releasing synapses on excitatory neurons [58, 59]; Bdnf,
which controls the maturation and function of inhibitory
synapses [60, 61]; Syt4, which regulates synaptic function
and plasticity by modulating BDNF release [62]; and
Gadd45g, a member of the Gadd45 family that is engaged
in the activity-induced demethylation of Bdnf promoters and
transcription [63]. Acan, as a component of perineuronal nets
around inhibitory interneurons, stabilizes synapses and restrict
their reorganization.
Another group of identified genes are those encoding
proteins regulating structural and physiological plasticity
of excitatory neurons. Lcn2, Pcdh8, and Elmo1 influ-
ence the electrophysiological properties of neurons by
either decreasing dendritic spine density or changing
their morphology [64–66]. These activity-induced pro-
teins may suppress the number of spines to dampen
synaptic function after elevated neuronal activity, similar
to other neural activity-regulated molecules, such as MEF2
and PLK2 [53, 67].
A third group of genes are genes that encode RNA-binding
proteins, such as Magoh and Zfp36, which regulate the
metabolism of mRNAs by targeting them for degradation
[68, 69].
The decreased production of proteins form any of men-
tioned above groups may explain the seizure-vulnerable phe-
notype observed in SRF KO animals. However, further stud-
ies are needed to address the specific role of SRF in the reg-
ulation of the balance between inhibition and activation in
neurons.
We found an increase in epileptogenesis in SRF KO ani-
mals, which is consistent with the results of several studies
that used animals with individual deletions of SRF-dependent
genes. The ablation of such genes as Npas4, Fos, and Arc
leads to increased seizure susceptibility [58, 70, 71]. The
in vitro disruption of Acan causes seizure-like activity in hip-
pocampal cultures [72]. Similarly, enhanced epileptiform re-
sponses were observed in slices from Syt4 KO animals [73].
Moreover, Lcn2-deficient neurons show increased excitability
[64, 74]. These proteins are induced by an increase in neuronal
activity and appear to play a role as endogenous inhibitors of
epilepsy; thus, impairment of their expression in SRF KO
mice could enhance the epileptic phenotype, as demonstrated
by the present results.
SRF-Controlled Genes Associated with Human Pathology
Although no evidence for the role of SRF in human
epilepsy was provided so far, it is important to note that
either deletion or insertion in the regions of SRF target
genes identified in our study was associated with human
neurological disorders (Table 3). Single-nucleotide poly-
morphisms identified within or in close proximity to
CArG boxes in humans were shown to be linked with
neurological disorders, such as bipolar disorder, amyo-
trophic lateral sclerosis, and Alzheimer’s disease [27].
Several SRF-controlled genes that were identified in
the present study (e.g., Cyr61, Bdnf, Zfp36, Fos, JunB)
are upregulated in the cortex in patients who suffer
from epilepsy. Statistically significant enrichment of
SREs on the proximal promoters in this group of genes
was observed [75].
In a group of genes that were downregulated in CTR ani-
mals after kainic acid-induced status epilepticus but not in KO
animals (Fig. 3b), we identified Cacna1h (Cav3.2). Mutations
in this gene are linked to a wide spectrum of idiopathic gen-
eralized epilepsies [76, 77] and influence neuronal excitability
[78, 79]. The lack of downregulation ofCacna1hmRNA after
status epilepticus in SRF KO mice may contribute to their
enhanced epileptic phenotype.
Molecular Mechanisms of SRF-Dependent Gene Regulation
Our results suggest that SRF can regulate gene expression by
two possible molecular mechanisms. The first mechanism is
direct binding to the gene promoters. We found in vivo en-
richment of SRF occupancy on promoters of Fos, Npas4,
Gadd45g, and Zfp36. Although Fos has been previously re-
ported to be regulated by SRF, this is the first report of which
we are aware on the direct regulation ofNpas4,Gadd45g, and
Zfp36 by SRF in neurons. Significant enrichment of SRF
binding to the new SRF targets was observed upon kainic acid
stimulation in the present study. The binding of SRF to DNA
can be constitutive, as observed for Fos, or inducible upon
stimulation [80].
The second mechanism involves other transcription
factors. Because of the relatively late time point ana-
lyzed in the microarray experiments (i.e., 6 h after sei-
zure induction), SRF targets may be indirectly regulated
through the activation of other genes that encode tran-
scription factors (e.g., Fos, Npas4, Egr1), similar to our
previous study that found that Mmp-9 was regulated in
neurons by SRF through Fos [81]. The identification of
several transcription factors, among SRF target genes,
that are important for neuronal plasticity suggests that
SRF may be a primary hub that can orchestrate the
regulation of several aspects of synaptic plasticity.
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Conclusions
Our data show that SRF is an important regulator of activity-
induced gene expression in neurons and may be involved in
the development of epilepsy. SRF regulates the expression
of several plasticity genes that together may decrease
hyperexcitation in response to a strong neuronal stimula-
tion. The lack of these genes may lead to the development
of a more severe TLE as a consequence of homeostatic
imbalance. Still, further studies are needed to determine
which of the identified SRF target genes are actually in-
volved in the development of epilepsy and what is the
molecular mechanism underlying this process. To address
this question, identified genes need to be analyzed indi-
vidually and their potential role in the context of epilepsy
should be assessed.
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